High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 555-560

  Majolino, I ^a   Saglio, G ^b   Scime R ^a   Serra, A ^b   Cavallaro, A M ^a   Fiandaca, T ^a   Vasta, S ^a   Pampinella, M ^a   Catania, P ^a   Indovina, A ^a   Marceno R ^a   Santoro, A ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Allo BMT; Chronic GVHD; PBSC

Indexed keywords

ACICLOVIR; BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; NYSTATIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APHERESIS; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; FEASIBILITY STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; HUMAN CELL; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; SIBLING; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

ADULT; BUSULFAN; CHIMERA; CYCLOPHOSPHAMIDE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 15844382914     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic transplants. Bone Marrow Transplant 1992; 9: 277-284.
2. Majolino I, Pearce R, Taghipour G, Goldstone AH. PBSCT vs ABMT in Hodgkin's and non-Hodgkin's lymphomas. A new matched-pair analysis of the EBMT Registry data. Bone Marrow Transplant 1995; 15: 162 (abstr.).
3. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4: 643-646.
4. Weaver CH, Buckner CD, Longin K et al. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981-1984.
5. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993; 81: 1883-1888.
6. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407 (letter).
7. Russell RH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341: 1482 (letter).
8. Bacigalupo A, Majolino I, Van Lint MT et al. Transplantation of rhG-CSF mobilized allaogeneic peripheral blood cells from HLA identical sibling donors. Bone Marrow Transplant 1995; 15 (Suppl. 2): 5 (abstr.).
9. Bensinger WI, Weaver CH, Appelbaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant granulocyte colony stimulating factor. Blood 1995; 85: 1659-1665.
10. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1655-1658.
11. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
12. Buscemi F, Fabbiano F, Felice R et al. Use of large polygonal gates for flow cytometry analysis of circulating progenitor cells. Bone Marrow Transplant 1993; 12: 305-306 (letter).
13. Deeg HJ, Storb BR, Graft-versus-host disease: pathophysiological and clinical aspects. Ann Rev Medicine 1984; 35: 11-24.
14. Gyapay G, Morisette J, Vignal A et al. The 1993-1994 Genethon human genetic linkage map. Nat Genet 1994; 7: 246-249.
15. Griffiths PD, Panjwani DD, Stirk PR et al. Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet 1984; ii: 1242-1244.
16. van der Bij W, Torensma R, van Son WJ et al. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 1988; 25: 179-188.
17. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
18. Carbonel F, Calvo W, Fliedner TM et al. Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimeras. Int J J Cell Clon 1984; 2: 81-88.
19. Molineux G, Pojda Z, Hampson IN et al. Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 1990; 76: 2153-2158.
20. Atkinson K, Farrell C, Chapman G et al. Female marrow donors increase the risk of acute graft-versus-host-disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986; 63: 231-239.
21. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after bone marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
22. Storb R, Etzioni R, Anasetti C et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994; 84: 941-949.
23. Kolb HJ, Mittermüller J, Clemm CH et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
24. Bemasconi P, Alessandrino EP, Caldera D et al. Intensive chemotherapy followed by donor PBSC in ANLL relapsed after allogeneic BMT. Bone Marrow Transplant 1995; 15: 643-645.